Author

Alexei Cuevas

Austral University of Chile

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:proteomics· 1

Frequent Co-Authors

Alberto Anastacio AmarillaiD· 1 shared Alejandro Rojas‐FernándeziD· 1 shared Alexander A. KhromykhiD· 1 shared Ananda MülleriD· 1 shared Andreas LangeriD· 1 shared Anne Berking· 1 shared Benjamín UbertiiD· 1 shared Camila Deride· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Alberto Anastacio AmarillaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity Nanobody.

Guillermo Valenzuela, Ronald Jara, Daniel Watterson, Naphak Modhiran, Alberto Anastacio Amarilla, Johanna Himelreichs, Alexander A. Khromykh, Constanza Salinas-Rebolledo, Teresa Pinto, Yorka Cheuquemilla, Yago Margolles, Natalia López‐González del Rey, Zaray Miranda-Chacón, Alexei Cuevas, Anne Berking, , Alejandro Rojas‐Fernández

The paper describes the development of a high-affinity Nanobody against SARS-CoV-2 RBD that neutralizes wild-type and D614G variants with nanomolar potency.

Scientific Reports · Feb 8, 2021Peer-reviewedMolecular Biology